Corton Capital Inc. Takes $374,000 Position in Lam Research Corporation $LRCX

Corton Capital Inc. purchased a new position in Lam Research Corporation (NASDAQ:LRCX) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 3,846 shares of the semiconductor company’s stock, valued at approximately $374,000.

Several other hedge funds also recently modified their holdings of the company. Freestone Capital Holdings LLC increased its holdings in shares of Lam Research by 180.2% during the second quarter. Freestone Capital Holdings LLC now owns 7,737 shares of the semiconductor company’s stock worth $753,000 after buying an additional 4,976 shares in the last quarter. Westside Investment Management Inc. grew its stake in shares of Lam Research by 3.5% during the second quarter. Westside Investment Management Inc. now owns 7,940 shares of the semiconductor company’s stock valued at $773,000 after purchasing an additional 270 shares during the last quarter. Texas Bank & Trust Co bought a new stake in shares of Lam Research during the second quarter valued at approximately $289,000. Bank of Montreal Can grew its stake in shares of Lam Research by 12.6% during the second quarter. Bank of Montreal Can now owns 1,400,232 shares of the semiconductor company’s stock valued at $136,299,000 after purchasing an additional 156,725 shares during the last quarter. Finally, Intellectus Partners LLC bought a new stake in shares of Lam Research during the second quarter valued at approximately $1,530,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on LRCX shares. Wells Fargo & Company raised their price objective on shares of Lam Research from $135.00 to $145.00 and gave the company an “equal weight” rating in a research note on Thursday, October 23rd. Raymond James Financial raised their price objective on shares of Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. The Goldman Sachs Group raised their price objective on shares of Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a research note on Wednesday, October 8th. TD Cowen raised their price objective on shares of Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Finally, Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Lam Research in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, Lam Research currently has an average rating of “Moderate Buy” and an average target price of $148.54.

Insider Activity

In other news, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction that occurred on Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the transaction, the insider directly owned 56,786 shares in the company, valued at approximately $8,942,091.42. The trade was a 13.69% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.31% of the company’s stock.

Lam Research Trading Down 2.2%

Shares of NASDAQ:LRCX opened at $157.46 on Monday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $165.22. The company’s fifty day simple moving average is $129.13 and its 200 day simple moving average is $103.49. The firm has a market cap of $197.77 billion, a price-to-earnings ratio of 34.68, a PEG ratio of 1.68 and a beta of 1.84.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company’s revenue was up 27.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th were issued a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 24th. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. Lam Research’s payout ratio is presently 22.91%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.